Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Cancers|September 14, 2024
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to BedsideElif Çakan, Olivia D Lara, Anna Szymanowska, et al.
International Journal of Molecular Sciences|March 4, 2017
Exosomes: From Garbage Bins to Promising Therapeutic TargetsMohammed H Rashed, Emine Bayraktar, Gouda K Helal, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancerHaci Ahmet Bircan, Nilgun Gurbuz, Apar Pataer, et al.
Gene|March 4, 2014
Investigation of the association between ATP2B4 and ATP5B genes with colorectal cancerEsra Geyik, Yusuf Ziya Igci, Elif Pala, et al.
Oncotarget|December 31, 2016
MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinaseRecep Bayraktar, Martin Pichler, Pinar Kanlikilicer, et al.
Cancer Medicine|August 8, 2024
Mechanism and rational combinations with GP-2250, a novel oxathiazine derivative, in ovarian cancerMark S Kim, Deanna Glassman, Katelyn F Handley, et al.
International Journal of Molecular Sciences|March 6, 2021
PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR PathwayAbdelrahman M Elsayed, Emine Bayraktar, Paola Amero, et al.
Molecular Cancer Therapeutics|June 6, 2020
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 InhibitorsTakahito M Miyake, Sunila Pradeep, Emine Bayraktar, et al.
Journal of Cancer Research and Clinical Oncology|January 30, 2022
Targeting CCR2<sup>+</sup> macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancerYutuan Wu, Nicholas B Jennings, Yunjie Sun, et al.
Cancers|June 2, 2021
Inactivating Mutations of the <i>IK</i> Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to ChemotherapyChao Gao, Guangxu Jin, Elizabeth Forbes, et al.
Pageof 5